This statistic depicts the share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage. According to data, the largest percentage of clinical studies approved by AIFA were in the second stage (37.3 percent), whereas only 2.3 percent of trials were conducted in the fourth stage.
Share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage
Profit from additional features by authenticating your Admin account
Please authenticate by going to "My account" → "Administration".
Then you will be able to mark statistics as favourites and use personal statistics alerts.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
Your perfect start with Statista
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract; Prices do not include sales tax.
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
The European House – Ambrosetti . (November 1, 2018). Share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage [Graph]. In Statista. Retrieved July 13, 2020, from https://www.statista.com/statistics/1015074/clinical-trials-of-novartis-approved-by-aifa-by-stage-in-italy/
The European House – Ambrosetti . "Share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage." Chart. November 1, 2018. Statista. Accessed July 13, 2020. https://www.statista.com/statistics/1015074/clinical-trials-of-novartis-approved-by-aifa-by-stage-in-italy/
The European House – Ambrosetti . (2018). Share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage. Statista. Statista Inc.. Accessed: July 13, 2020. https://www.statista.com/statistics/1015074/clinical-trials-of-novartis-approved-by-aifa-by-stage-in-italy/
The European House – Ambrosetti . "Share of Clinical Trials Funded by Novartis Approved by Aifa (Italian Pharmaceutical Agency) in Italy in 2017, by Stage." Statista, Statista Inc., 1 Nov 2018, https://www.statista.com/statistics/1015074/clinical-trials-of-novartis-approved-by-aifa-by-stage-in-italy/
The European House – Ambrosetti , Share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage Statista, https://www.statista.com/statistics/1015074/clinical-trials-of-novartis-approved-by-aifa-by-stage-in-italy/ (last visited July 13, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
